SCHEMBL477841

SCHEMBL477841

CC(C)(C)[C@H](N)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29990102 1.00
SCHEMBL140065 1.00
SCHEMBL754075 1.00
Hydrochloric Acid SCHEMBL605748 0.97
Water SCHEMBL1333599 0.97
SCHEMBL6844415 0.91 DPP4 (0.30)
SCHEMBL29617116 0.83
SCHEMBL10363136 0.83
SCHEMBL12538862 0.78
SCHEMBL9798387 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4049681-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR AND USES THEREOF NEUROCRINE BIOSCIENCES INC (US) 2026-01-07 EP claimed
EP-4017494-B1 THE VMAT2 INHIBITOR VALBENAZINE FOR USE IN A METHOD OF TREATING A NEUROLOGICAL OR PSYCHIATRIC DISORDER IN PATIENTS WITH SEVERE RENAL IMPAIRMENT NEUROCRINE BIOSCIENCES INC (US) 2025-08-20 EP claimed
EP-4323062-B1 HETEROARYL AMINOPROPANOL DERIVATIVES AS INHIBITORS OF LTA4H NOVARTIS AG (CH) 2025-07-23 EP claimed
CN-120025542-A Non-isocyanate polyurethane and multicomponent selective synthesis method thereof 华南理工大学 2025-05-23 CN claimed
CN-119119087-A Chiral binuclear copper complex with benzo [ c ] cinnoline skeleton and preparation method thereof 中国科学院上海有机化学研究所 2024-12-13 CN claimed
CN-118791526-A Chiral aryl phosphine-oxazoline functionalized porous organic polymer and preparation and application thereof 浙江工业大学 2024-10-18 CN claimed
US-20240165109-A1 Methods of Treatment with Selective CB2 Receptor Agonists ARENA PHARMACEUTICALS, INC. (US) 2024-05-23 US claimed
CN-115160158-B Preparation method of chiral tertiary leucinol 泰州天鸿生化科技有限公司 2024-04-26 CN claimed
EP-3936130-B1 VALBENAZINE DOSAGE REGIMEN FOR THE TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS NEUROCRINE BIOSCIENCES INC (US) 2024-02-14 EP claimed
CN-117402193-A Chiral oxazoline-cobalt picolinite compound and synthetic method and application thereof 郑州大学 2024-01-16 CN claimed
US-20150126477-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. 2015-05-07 US claimed
US-20140206649-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. 2014-07-24 US claimed
US-8778950-B2 Cannabinoid receptor modulators ARENA PHARMACEUTICALS, INC. (US) 2014-07-15 US claimed
US-20140135345-A1 CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. 2014-05-15 US claimed
US-20120214766-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. 2012-08-23 US claimed
EP-2470508-A1 CANNABINOID RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2012-07-04 EP claimed
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2012-02-16 US claimed
EP-1981831-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF Vaidya, Niteen A. (US) 2008-10-22 EP claimed
WO-2007092264-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2007-08-16 WO claimed
US-20070185346-A1 Kit for automated resolving agent selection and method thereof VAIDYA NITEEN A 2007-08-09 US claimed